PCR-based amplification of circulating RNAs as prognostic and predictive biomarkers - Focus on neuroblastoma.

about

PCR-based amplification of circulating RNAs as prognostic and predictive biomarkers - Focus on neuroblastoma.

Item

http://www.wikidata.org/entity/Q52816741

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

PCR-based amplification of cir ...... kers - Focus on neuroblastoma.

@en

PCR-based amplification of cir ...... kers - Focus on neuroblastoma.

@nl

type

Item

label

PCR-based amplification of cir ...... kers - Focus on neuroblastoma.

@en

PCR-based amplification of cir ...... kers - Focus on neuroblastoma.

@nl

prefLabel

PCR-based amplification of cir ...... kers - Focus on neuroblastoma.

@en

PCR-based amplification of cir ...... kers - Focus on neuroblastoma.

@nl

P1154

2-s2.0-85015440334

http://www.w3.org/2001/XMLSchema#string

P1433

Practical Laboratory Medicine

P1476

PCR-based amplification of cir ...... kers - Focus on neuroblastoma.

@en

P2093

Sam C Brownhill

http://www.w3.org/2001/XMLSchema#string

Sue A Burchill

http://www.w3.org/2001/XMLSchema#string

P2860

Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers.

Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.

Molecular detection of low-level disease in patients with cancer.

Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.

Detection of bone marrow micrometastasis and microcirculating disease in rhabdomyosarcoma by a real-time RT-PCR assay.

The International Neuroblastoma Pathology Classification (the Shimada system).

Bone marrow minimal residual disease was an early response marker and a consistent independent predictor of survival after anti-GD2 immunotherapy.

Low specificity of PGP9.5 expression for detection of micrometastatic neuroblastoma

Detection, clinical relevance and specific biological properties of disseminating tumour cells.

Exploiting gene expression profiling to identify novel minimal residual disease markers of neuroblastoma.

P304

41-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PLABM.2016.04.003

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5530

7324298

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1028162281

http://www.w3.org/2001/XMLSchema#string

P6409

145100906

http://www.w3.org/2001/XMLSchema#string

P698

28856217

http://www.w3.org/2001/XMLSchema#string

P932

5575362

http://www.w3.org/2001/XMLSchema#string

P953

99117